What topical corticosteroid (steroid) is recommended for a patient with eczema (atopic dermatitis) around the face and eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical Corticosteroid Selection for Facial and Periocular Eczema

For eczema around the face and eyes, low-potency topical corticosteroids such as hydrocortisone 1% are recommended as first-line treatment, with preservative-free dexamethasone 0.1% for moderate-to-severe cases requiring short-term use only. 1

Potency Selection Based on Location

  • For facial and periocular eczema, use low-potency topical corticosteroids first due to the thin skin in these areas and increased risk of adverse effects 1, 2
  • For moderate-to-severe periocular eczema, preservative-free dexamethasone 0.1% may be appropriate for short-term use (maximum 8 weeks) 1
  • Avoid potent and very potent topical corticosteroids on the face and around eyes due to significantly increased risk of skin thinning and other local adverse effects 1, 2

Application Guidelines

  • Apply topical corticosteroids once daily for facial eczema, as twice-daily application does not improve efficacy but increases risk of side effects 3
  • Use the fingertip unit method for appropriate dosing (one fingertip unit covers an area equivalent to two adult palms) 2
  • Apply after bathing when skin is slightly damp for better absorption 4

Duration of Treatment

  • Use topical corticosteroids for short courses to control flares 1
  • For moderate-to-severe periocular eczema requiring dexamethasone 0.1%, limit treatment to a maximum of 8 weeks 1
  • Consider early introduction of steroid-sparing agents (tacrolimus ointment or ciclosporin drops) to facilitate tapering of ocular corticosteroids 1

Monitoring and Side Effects

  • Monitor for signs of skin atrophy, telangiectasia, or striae, particularly in the periocular region 4, 5
  • Be aware that the risk of adverse effects increases with prolonged use, higher potency, and application to areas of thinner skin such as the face 2
  • Preservative-free formulations are recommended for periocular use due to increased incidence of allergic contact dermatitis 1

Adjunctive Therapies

  • Use emollients regularly as soap substitutes and moisturizers 1, 4
  • Apply emollients at least 30 minutes before or after topical corticosteroids 4
  • For severe pruritus, sedating antihistamines may be useful as a short-term adjuvant during relapses 1, 6
  • Non-sedating antihistamines have little to no value in treating facial eczema 1, 7

Treatment-Resistant Cases

  • If no improvement after 4 weeks of appropriate treatment, consider referral to a dermatologist 4, 6
  • For treatment-resistant periocular disease, consider combination treatment with topical corticosteroids, tacrolimus ointment, and ciclosporin drops in carefully selected cases 1

Special Considerations

  • Avoid soaps and detergents as they remove natural lipids from the skin surface 1
  • Use dispersible cream as a soap substitute to cleanse the skin 1
  • Keep nails short to minimize damage from scratching 1
  • Evaluate for secondary bacterial infection if treatment is not effective 6
  • Consider patch testing to identify potential contact allergens that may be exacerbating the condition 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical Corticosteroids: Choice and Application.

American family physician, 2021

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Guideline

Topical Corticosteroid Treatment for Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Moderate Facial Eczema Unresponsive to Moderate Potency Topical Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Dyshidrosis Eczema with Topical Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.